GO:0090149 mitochondrial membrane fission: Mechanism, Genes

Mitochondria are dynamic organelles that continuously undergo fusion and fission to maintain their shape, number, and function. The term GO:0090149 mitochondrial membrane fission describes the cellular process that physically separates a single continuous mitochondrial membrane into two distinct membranes, a key step in mitochondrial division. This process is not merely a mechanical event but is tightly regulated by a dedicated protein machinery that includes dynamin-related GTPases, adaptor proteins, and membrane-shaping factors. Understanding mitochondrial membrane fission is fundamental for researchers studying organelle dynamics, cellular stress responses, and the pathogenesis of numerous human diseases. Over the past two decades, studies have revealed that mitochondrial membrane fission occurs at specific sites and is coupled to diverse cellular outcomes, ranging from mitochondrial biogenesis to the elimination of damaged organelles. The discovery of distinct fission signatures, such as midzone and peripheral fission, has provided new insights into how cells decide the fate of mitochondrial fragments. Moreover, biophysical studies have shown that membrane tension and lipid composition directly influence the efficiency of the fission reaction. These findings underscore the importance of mitochondrial membrane fission as a central node in mitochondrial quality control and cellular homeostasis. For researchers, mitochondrial membrane fission represents a rich area of investigation, with implications for understanding fundamental cell biology and for developing therapeutic strategies targeting mitochondrial dysfunction. The availability of CRISPR-based genome editing tools now allows precise manipulation of genes involved in this process, enabling causal studies in relevant cell models. This article provides a comprehensive overview of the definition, molecular mechanism, key genes, regulation, disease links, and research methods associated with GO:0090149 mitochondrial membrane fission.

According to the Gene Ontology, GO:0090149 mitochondrial membrane fission is a biological process that occurs at the cellular level and results in the separation of a single continuous mitochondrial membrane into two membranes, thereby contributing to mitochondrial fission. This definition emphasizes the membrane scission event itself, distinguishing it from the broader process of mitochondrial division, which includes additional steps such as recruitment of the fission machinery and organelle constriction. The term is also known by synonyms such as membrane fission involved in mitochondrial fission and mitochondrial membrane scission.

Mitochondrial membrane fission is essential for maintaining mitochondrial health and function, as it enables the removal of damaged mitochondrial components, facilitates the distribution of mitochondria during cell division, and participates in programmed cell death. Dysregulation of this process has been linked to a wide range of human pathologies, including neurodegenerative diseases, cancer, and metabolic syndromes. Therefore, understanding the molecular mechanisms of mitochondrial membrane fission is not only a fundamental cell biology question but also a critical step toward developing targeted therapies for these conditions.

The following table lists key genes and proteins that are directly involved in or regulate mitochondrial membrane fission, based on published literature.

Mitochondrial membrane fission is regulated at multiple levels, including post-translational modifications of DRP1 and its adaptors, such as phosphorylation, ubiquitination, SUMOylation, and S-nitrosylation. For example, phosphorylation of DRP1 at Ser616 by CDK1/cyclin B promotes fission during mitosis, while phosphorylation at Ser637 by PKA inhibits fission. The process is also controlled by cellular energy status via AMPK and mTOR signaling, which influence mitochondrial dynamics to match metabolic demand. Additionally, calcium signaling and reactive oxygen species can modulate fission machinery recruitment. Recent studies have highlighted the role of membrane lipids, such as phosphatidic acid and cardiolipin, in regulating fission site assembly and scission. The interplay between fission and fusion is further fine-tuned by the inner membrane protein MTFP1, which controls inner membrane quality and mtDNA levels.

Dysregulated mitochondrial membrane fission is increasingly recognized as a contributor to neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Charcot-Marie-Tooth disease type 2A. Mutations in MFN2, which normally promotes fusion, cause Charcot-Marie-Tooth disease, highlighting the importance of fission-fusion balance. In Parkinson's disease, impaired clearance of damaged mitochondria due to altered fission can lead to dopaminergic neuron loss. Targeting fission machinery, such as DRP1, is being explored as a therapeutic strategy in preclinical models.

Cancer cells often exhibit increased mitochondrial fission, which supports their high metabolic demands and rapid proliferation. Elevated DRP1 expression and activity have been observed in several cancer types, and inhibition of DRP1 can reduce tumor growth in preclinical models. Moreover, fission promotes resistance to apoptosis, making it a potential target for anticancer therapy. The role of fission in cancer is complex, as it can also influence metastasis and stemness.

Altered mitochondrial dynamics, including excessive fission, are linked to insulin resistance, obesity, and type 2 diabetes. In skeletal muscle and adipose tissue, fission-fusion imbalance contributes to impaired mitochondrial function and metabolic inflexibility. Modulating fission may offer therapeutic benefits for metabolic diseases.

Live-cell fluorescence microscopy using mitochondria-targeted fluorescent proteins (e.g., mito-GFP) is a primary method to visualize mitochondrial membrane fission events in real time. Time-lapse imaging allows researchers to track fission frequency, location, and morphology. Advanced techniques such as stimulated emission depletion (STED) microscopy and lattice light-sheet microscopy provide higher resolution to observe membrane constriction and scission.

CRISPR-Cas9 genome editing enables the generation of knockout, point-mutation, knock-in, and overexpression cell models to study the function of genes involved in mitochondrial membrane fission. Knockout of DNM1L, MFF, or other fission genes results in elongated mitochondrial networks, confirming their roles. Point mutations can dissect phosphorylation sites or GTPase activity, while knock-in of tags facilitates protein localization and interaction studies.

Co-immunoprecipitation and mass spectrometry can identify protein-protein interactions within the fission machinery. Proteomics of isolated mitochondria from wild-type and mutant cells reveals changes in protein abundance and post-translational modifications. GTPase activity assays measure the enzymatic function of DRP1 and related proteins.

Mitophagy flux assays, mitochondrial membrane potential measurements, and ATP production assays assess the functional consequences of altered fission. Seahorse extracellular flux analysis measures oxidative phosphorylation and glycolysis in cells with fission defects. These assays link molecular changes to cellular physiology.

Researchers studying mitochondrial membrane fission-related genes often need to determine whether a candidate gene is causally involved in the process, how specific mutations affect protein function, and what the downstream cellular consequences are. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that address these questions, from knockout to knock-in and overexpression, supported by library screening and bioinformatics.

Mitochondrial membrane fission (GO:0090149) is a fundamental cellular process that governs mitochondrial morphology, quality control, and cell fate. The molecular machinery, centered on DRP1 and its adaptors, is tightly regulated and responsive to metabolic and stress signals. Dysregulation of fission contributes to a spectrum of human diseases, making it an attractive target for therapeutic intervention. Advances in CRISPR-based genome editing and imaging technologies continue to unravel the complexities of this process, offering new opportunities for research and drug discovery.